We only have this paper's title and publication details.
Read it at the sourceExon skipping of SLK increases phosphoenolpyruvate in tumors, suggesting a link to poor patient outcomes.
Exon skipping of SLK promotes PEP accumulation and predicts poor prognosis
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: